136 related articles for article (PubMed ID: 34241785)
1. Proteomics study of Mycoplasma pneumoniae pneumonia reveals the Fc fragment of the IgG-binding protein as a serum biomarker and implicates potential therapeutic targets.
Liu J; Shen R; Feng L; Cheng S; Chen J; Xiao T; Zhao S
Front Med; 2022 Jun; 16(3):378-388. PubMed ID: 34241785
[TBL] [Abstract][Full Text] [Related]
2. Serum cytokine profiling reveals different immune response patterns during general and severe
Zhang Z; Dou H; Tu P; Shi D; Wei R; Wan R; Jia C; Ning L; Wang D; Li J; Dong Y; Xin D; Xu B
Front Immunol; 2022; 13():1088725. PubMed ID: 36618370
[No Abstract] [Full Text] [Related]
3. A comparative study of general and severe mycoplasma pneumoniae pneumonia in children.
Yang S; Lu S; Guo Y; Luan W; Liu J; Wang L
BMC Infect Dis; 2024 Apr; 24(1):449. PubMed ID: 38671341
[TBL] [Abstract][Full Text] [Related]
4. Prediction Model for Severe Mycoplasma pneumoniae Pneumonia in Pediatric Patients by Admission Laboratory Indicators.
Chang Q; Chen HL; Wu NS; Gao YM; Yu R; Zhu WM
J Trop Pediatr; 2022 Jun; 68(4):. PubMed ID: 35903920
[TBL] [Abstract][Full Text] [Related]
5. Optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe mycoplasma pneumoniae pneumonia.
Wu X; Lu W; Wang T; Xiao A; Guo X; Xu Y; Li S; Liu X; Zeng H; He S; Zhang X
BMC Infect Dis; 2023 Oct; 23(1):661. PubMed ID: 37798699
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China: 2006 to 2016.
Gao LW; Yin J; Hu YH; Liu XY; Feng XL; He JX; Liu J; Guo Y; Xu BP; Shen KL
Epidemiol Infect; 2019 Jan; 147():e192. PubMed ID: 31364532
[TBL] [Abstract][Full Text] [Related]
7. Proteomic and mechanistic study of Qingxuan Tongluo formula and curcumin in the treatment of Mycoplasma pneumoniae pneumonia.
Wei L; Zhong W; Sun T; Li H; Sun T; Han Y; Sun D; Li X
Biomed Pharmacother; 2021 Jan; 133():110998. PubMed ID: 33378995
[TBL] [Abstract][Full Text] [Related]
8. Vitamin A deficiency is associated with severe
Xing Y; Sheng K; Xiao X; Li J; Wei H; Liu L; Zhou W; Tong X
Ann Transl Med; 2020 Feb; 8(4):120. PubMed ID: 32175413
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic values of soluble triggering receptor expressed on myeloid cells (sTREM-1) and interferon-inducible protein-10 (IP-10) for severe mycoplasma pneumoniae pneumonia in children.
Xu C; Luo LY; Wu BC; Ding N; Jin SJ; Huang JB; Chen YP
Clinics (Sao Paulo); 2024; 79():100361. PubMed ID: 38678873
[TBL] [Abstract][Full Text] [Related]
10. D-dimer: The Risk Factor of Children's Severe Mycoplasma Pneumoniae Pneumonia.
Qiu J; Ge J; Cao L
Front Pediatr; 2022; 10():828437. PubMed ID: 35498793
[TBL] [Abstract][Full Text] [Related]
11. Molecular and clinical characteristics of severe Mycoplasma pneumoniae pneumonia in children.
Yan C; Xue G; Zhao H; Feng Y; Li S; Cui J; Ni S; Sun H
Pediatr Pulmonol; 2019 Jul; 54(7):1012-1021. PubMed ID: 31119869
[TBL] [Abstract][Full Text] [Related]
12. Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children.
Tsai TA; Tsai CK; Kuo KC; Yu HR
J Microbiol Immunol Infect; 2021 Aug; 54(4):557-565. PubMed ID: 33268306
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of the Clinical Efficacy and Safety of High- and Low-dose Methylprednisolone in the Treatment of Children With Severe Mycoplasma Pneumoniae Pneumonia.
Sun LL; Ye C; Zhou YL; Zuo SR; Deng ZZ; Wang CJ
Pediatr Infect Dis J; 2020 Mar; 39(3):177-183. PubMed ID: 31738328
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary Thrombotic Complication of Mycoplasma pneumoniae Pneumonia in Chinese Children: Clinical Feature and Risk Factor Analysis.
Yu Y; Jin X; Zhang X; Shen Y
Pediatr Infect Dis J; 2024 Jun; 43(6):505-510. PubMed ID: 38359345
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between Mycoplasma pneumoniae DNA replication level and disease severity in children with severe Mycoplasma pneumoniae pneumonia].
Fang KN; Wang J; Ni JW
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Sep; 21(9):876-880. PubMed ID: 31506145
[TBL] [Abstract][Full Text] [Related]
16. Changes in coagulation markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for Mycoplasma severity.
Li YT; Zhang J; Wang MZ; Ma YM; Zhi K; Dai FL; Li SJ
Ital J Pediatr; 2023 Oct; 49(1):143. PubMed ID: 37858230
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of Serum ELISA of Mycoplasma Pneumoniae IgM and IgG and Passive Particle Agglutination for Mycoplasma Pneumoniae Pneumonia in Children.
Ge M; Song Q; Guo Q; Zhou L; Li J; Li Z; Ma L
Clin Lab; 2021 Jan; 67(1):. PubMed ID: 33491435
[TBL] [Abstract][Full Text] [Related]
18. The study of routine laboratory factors in children with mycoplasma pneumoniae pneumonia: serum uric acid may have anti-inflammatory effect.
Pan C; Chen Y; Wang S; Li M; Qu S
J Clin Lab Anal; 2021 Nov; 35(11):e24026. PubMed ID: 34655117
[TBL] [Abstract][Full Text] [Related]
19. The Clinical Value of Systemic Immune Inflammation Index (SII) in Predicting the Severity of Hospitalized Children with Mycoplasma Pneumoniae Pneumonia: A Retrospective Study.
Wang S; Wan Y; Zhang W
Int J Gen Med; 2024; 17():935-942. PubMed ID: 38495920
[TBL] [Abstract][Full Text] [Related]
20. A new dynamic nomogram for predicting the risk of severe Mycoplasma pneumoniae pneumonia in children.
Zhang X; Sun R; Jia W; Li P; Song C
Sci Rep; 2024 Apr; 14(1):8260. PubMed ID: 38589453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
